PhaseBio Pharmaceuticals Inc. (PHAS) Slipped -11.92% or -1.56 To Price $11.56 On Wednesday

PhaseBio Pharmaceuticals Inc. (PHAS) slipped -11.92% or -1.56 to $11.56. It is nearly 252455 shares traded, which is 39.1% compare to the average total volume 645731. The market cap of PHAS is $331.07 million. The year to date change is 306.9%. The 52 week price range is from $2.55 to $16.65. Price of PHAS have changed -1.20% during last week. It have changed -0.98% over last month, N/A N/A and 162.60% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PHAS is 10.14. It is -12.28% below current price. The 200-day Moving Averages for PHAS is 5.99. It is -48.18% below current price. The 52-week High is 16.65. It is 44.03% from the current price. The 52-week Low is 2.55. It is -77.94% from current price.

There are some statistics of PHAS. It is has market cap $331.07 million. The share outstanding is 28.62 million. The average volume is 645731. The percent of top 15 Institution holding is 31.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is 112.68%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -62.32%.


Share this post